Detection of Human papillomavirus and the role of p16INK4a in colorectal carcinomas

PLoS One. 2020 Jun 25;15(6):e0235065. doi: 10.1371/journal.pone.0235065. eCollection 2020.

Abstract

Introduction: Human papillomavirus (HPV) infection is associated with the development of anogenital and head and neck cancers. In recent years a potential role of HPV in colorectal cancer (CRC) has been suggested.

Objective: To investigate the presence of HPV in colorectal carcinomas and to study the role of p16INK4a as a marker of transcriptionally active HPV infection. In addition, to investigate the correlation between these findings and the CRC prognostic factors.

Methods: Case control study with 92 cases of colorectal cancers, 75 controls of normal tissue adjacent to the tumor, and 30 controls of precursor lesions, including polyps and colorectal adenomas. Paraffinized samples were used, HPV detection and genotyping were performed by PCR and reverse hybridization by using the INNO LIPA kit, with SPF10 plus primers. The expression of the p16INK4a protein was investigated using immunohistochemistry. Data analysis was performed using descriptive, univariate statistics and survival curves were calculated by using the Kaplan Meier and log-rank method.

Results: HPV was detected in 13% of the cases and the most prevalent genotype was HPV 16. HPV DNA was not detected in either control groups. The high expression of p16INK4a was observed in 30% of the cases, but it was not associated to the presence of HPV. The overall survival was 53.3% and was influenced by prognostic factors such as later stage, lymph node and distant metastasis.

Conclusions: Based on these results, HPV is unlikely to be involved in colorectal carcinogenesis and p16INK4a expression is not a relevant marker of transcriptionally active HPV infection in CRC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Colorectal Neoplasms* / genetics
  • Colorectal Neoplasms* / metabolism
  • Colorectal Neoplasms* / pathology
  • Colorectal Neoplasms* / virology
  • Cyclin-Dependent Kinase Inhibitor p16* / biosynthesis
  • Cyclin-Dependent Kinase Inhibitor p16* / genetics
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Human papillomavirus 16* / genetics
  • Human papillomavirus 16* / metabolism
  • Humans
  • Male
  • Middle Aged
  • Papillomavirus Infections* / genetics
  • Papillomavirus Infections* / metabolism
  • Papillomavirus Infections* / pathology

Substances

  • CDKN2A protein, human
  • Cyclin-Dependent Kinase Inhibitor p16

Grants and funding

Fundação de Amparo à Pesquisa do Estado de Goiás (FAPEG); Programa Pesquisa para o Sistema Único de Saúde (PPSUS), Ministério da Saúde (MS); Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.